BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24442640)

  • 1. Redesigning the procaspase-8 dimer interface for improved dimerization.
    Ma C; MacKenzie SH; Clark AC
    Protein Sci; 2014 Apr; 23(4):442-53. PubMed ID: 24442640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of proteolysis in caspase-8 activation and stabilization.
    Pop C; Fitzgerald P; Green DR; Salvesen GS
    Biochemistry; 2007 Apr; 46(14):4398-407. PubMed ID: 17371051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and biochemical studies on procaspase-8: new insights on initiator caspase activation.
    Keller N; Mares J; Zerbe O; Grütter MG
    Structure; 2009 Mar; 17(3):438-48. PubMed ID: 19278658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inducible dimerization and inducible cleavage reveal a requirement for both processes in caspase-8 activation.
    Oberst A; Pop C; Tremblay AG; Blais V; Denault JB; Salvesen GS; Green DR
    J Biol Chem; 2010 May; 285(22):16632-42. PubMed ID: 20308068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interdimer processing mechanism of procaspase-8 activation.
    Chang DW; Xing Z; Capacio VL; Peter ME; Yang X
    EMBO J; 2003 Aug; 22(16):4132-42. PubMed ID: 12912912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folding and assembly kinetics of procaspase-3.
    Milam SL; Clark AC
    Protein Sci; 2009 Dec; 18(12):2500-17. PubMed ID: 19798740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Slow folding and assembly of a procaspase-3 interface variant.
    Mackenzie SH; Clark AC
    Biochemistry; 2013 May; 52(20):3415-27. PubMed ID: 23614869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the procaspase-3 dimer interface affect the activity of the zymogen.
    Pop C; Feeney B; Tripathy A; Clark AC
    Biochemistry; 2003 Oct; 42(42):12311-20. PubMed ID: 14567692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for dimerization of the death effector domain of the F122A mutant of Caspase-8.
    Shen C; Pei J; Guo X; Zhou L; Li Q; Quan J
    Sci Rep; 2018 Nov; 8(1):16723. PubMed ID: 30425291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The M476W/Q482H mutation of procaspase-8 restored caspase-8-mediated apoptosis.
    Li M; Le Wei ; Zhang XM; Zhang YJ; Jiang J; Liu PY
    Biochem Biophys Res Commun; 2019 Jun; 514(3):653-658. PubMed ID: 31078261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A constitutively active and uninhibitable caspase-3 zymogen efficiently induces apoptosis.
    Walters J; Pop C; Scott FL; Drag M; Swartz P; Mattos C; Salvesen GS; Clark AC
    Biochem J; 2009 Dec; 424(3):335-45. PubMed ID: 19788411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caspase-8 tyrosine-380 phosphorylation inhibits CD95 DISC function by preventing procaspase-8 maturation and cycling within the complex.
    Powley IR; Hughes MA; Cain K; MacFarlane M
    Oncogene; 2016 Oct; 35(43):5629-5640. PubMed ID: 27109099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interdimer processing and linearity of procaspase-3 activation. A unifying mechanism for the activation of initiator and effector caspases.
    Liu H; Chang DW; Yang X
    J Biol Chem; 2005 Mar; 280(12):11578-82. PubMed ID: 15664982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryo-EM structural analysis of FADD:Caspase-8 complexes defines the catalytic dimer architecture for co-ordinated control of cell fate.
    Fox JL; Hughes MA; Meng X; Sarnowska NA; Powley IR; Jukes-Jones R; Dinsdale D; Ragan TJ; Fairall L; Schwabe JWR; Morone N; Cain K; MacFarlane M
    Nat Commun; 2021 Feb; 12(1):819. PubMed ID: 33547302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of procaspase-8 activation by c-FLIPL.
    Yu JW; Jeffrey PD; Shi Y
    Proc Natl Acad Sci U S A; 2009 May; 106(20):8169-74. PubMed ID: 19416807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of the molecular mechanism of caspase-8 activation by solution NMR.
    Keller N; Grütter MG; Zerbe O
    Cell Death Differ; 2010 Apr; 17(4):710-8. PubMed ID: 19851329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineered hybrid dimers: tracking the activation pathway of caspase-7.
    Denault JB; Békés M; Scott FL; Sexton KM; Bogyo M; Salvesen GS
    Mol Cell; 2006 Aug; 23(4):523-33. PubMed ID: 16916640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dimer formation drives the activation of the cell death protease caspase 9.
    Renatus M; Stennicke HR; Scott FL; Liddington RC; Salvesen GS
    Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14250-5. PubMed ID: 11734640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new C-terminal cleavage product of procaspase-8, p30, defines an alternative pathway of procaspase-8 activation.
    Hoffmann JC; Pappa A; Krammer PH; Lavrik IN
    Mol Cell Biol; 2009 Aug; 29(16):4431-40. PubMed ID: 19528225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization.
    Srinivasula SM; Ahmad M; Fernandes-Alnemri T; Alnemri ES
    Mol Cell; 1998 Jun; 1(7):949-57. PubMed ID: 9651578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.